AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
COMBINATION OF ORAL IDARUBICIN AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF ADVANCED BREAST-CANCER
Authors: WILTSCHKE C MACA M BRODOWICZ T VALENTA B ZIELINSKI C
Citation: C. Wiltschke et al., COMBINATION OF ORAL IDARUBICIN AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF ADVANCED BREAST-CANCER, European journal of cancer, 34, 1998, pp. 40-40
2ND-LINE AND 3RD-LINE TREATMENT OF METASTATIC BREAST-CANCER WITH GEMCITABINE
Authors: BRODOWICZ T MOSLINGER R HERSCOVICI V VACLAVIK I WILTSCHKE C KUBISTA E ZIELINSKI C
Citation: T. Brodowicz et al., 2ND-LINE AND 3RD-LINE TREATMENT OF METASTATIC BREAST-CANCER WITH GEMCITABINE, European journal of cancer, 34, 1998, pp. 180-180
ANTI-HER2 NEU-ANTIBODY BINDING PROFILE IN PATIENTS WITH BREAST-CANCER/
Authors: JASINSKA J ZEILLINGER R HOFFMANNSOMMERGRUBER K SCHEINER O WILTSCHKE C ZIELINSKI CC
Citation: J. Jasinska et al., ANTI-HER2 NEU-ANTIBODY BINDING PROFILE IN PATIENTS WITH BREAST-CANCER/, European journal of cancer, 34, 1998, pp. 25-25
DECREASED EXPRESSION OF ICAM-1 AND ITS INDUCTION BY CYTOKINES ON MACROPHAGES FROM PATIENTS WITH BREAST-CANCER
Authors: BUDINSKY AC BRODOWICZ T WILTSCHKE C ZIELINSKI CC
Citation: Ac. Budinsky et al., DECREASED EXPRESSION OF ICAM-1 AND ITS INDUCTION BY CYTOKINES ON MACROPHAGES FROM PATIENTS WITH BREAST-CANCER, Annals of oncology, 9, 1998, pp. 578-578
ARTERIAL HEPATIC EMBOLIZATION OF UNRESECTABLE HEPATOCELLULAR-CARCINOMA USING A CYANOACRYLATE LIPIODOL MIXTURE/
Authors: BERGHAMMER P PFEFFEL F WINKELBAUER F WILTSCHKE C SCHENK T LAMMER J MULLER C ZIELINSKI C
Citation: P. Berghammer et al., ARTERIAL HEPATIC EMBOLIZATION OF UNRESECTABLE HEPATOCELLULAR-CARCINOMA USING A CYANOACRYLATE LIPIODOL MIXTURE/, Cardiovascular and interventional radiology, 21(3), 1998, pp. 214-218
PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH METASTATIC UROTHELIAL CANCER - RESULTS OF A PHASE-II TRIAL
Authors: ZIELINSKI CC SCHNACK B GRBOVIC M BRODOWICZ T WILTSCHKE C STEGER G PFLUGER H MARBERGER M
Citation: Cc. Zielinski et al., PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH METASTATIC UROTHELIAL CANCER - RESULTS OF A PHASE-II TRIAL, British Journal of Cancer, 78(3), 1998, pp. 370-374
GEMCITABINE-INDUCED HEMOLYTIC-UREMIC SYNDROME - A CASE-REPORT
Authors: BRODOWICZ T BREITENEDER S WILTSCHKE C ZIELINSKI CC
Citation: T. Brodowicz et al., GEMCITABINE-INDUCED HEMOLYTIC-UREMIC SYNDROME - A CASE-REPORT, Journal of the National Cancer Institute, 89(24), 1997, pp. 1895-1896
COOPERATIVE STUDY OF SOFT-TISSUE SARCOMA - FIRST RESULTS
Authors: BRODOWICZ T WILTSCHKE C KRAINER M RITSCHL P WINDHAGER R DOBROWSKY W POTTER R AMMAN G LANG S SALZERKUNTSCHIK M KOTZ R ZIELINSKI CC
Citation: T. Brodowicz et al., COOPERATIVE STUDY OF SOFT-TISSUE SARCOMA - FIRST RESULTS, European journal of cancer, 33, 1997, pp. 513-513
TC-99M-TETROFOSMIN IN BREAST-CANCER
Authors: BERGHAMMER P OBWEGESER R KARANIKAS G ULM M WILTSCHKE C KUBISTA E SINZINGER H ZIELINSKI CC
Citation: P. Berghammer et al., TC-99M-TETROFOSMIN IN BREAST-CANCER, European journal of cancer, 33, 1997, pp. 707-707
UROTHELIAL CANCER
Authors: SCHNACK B BRODOWICZ T WILTSCHKE C SCHOLTEN C ZIELINSKI CC
Citation: B. Schnack et al., UROTHELIAL CANCER, The Cancer journal, 10(3), 1997, pp. 146-150
A RANDOMIZED ADJUVANT BREAST-CANCER TRIAL COMPARING CONVENTIONAL WITHPERIOPERATIVE INITIATION OF CHEMOTHERAPY
Authors: KRAINER M BRODOWICZ T SEVELDA P WILTSCHKE C SMITH T SCHOLTEN C SEIFERT M DADAK C MAROSI C KUBISTA E ZIELINSKI CC
Citation: M. Krainer et al., A RANDOMIZED ADJUVANT BREAST-CANCER TRIAL COMPARING CONVENTIONAL WITHPERIOPERATIVE INITIATION OF CHEMOTHERAPY, The Cancer journal, 10(2), 1997, pp. 106-111
ISOLATED LIMB PERFUSION WITH HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA INCOMBINATION WITH INTERFERON-GAMMA AND MELPHALAN FOR NONRESECTABLE EXTREMITY SOFT-TISSUE SARCOMAS - A MULTICENTER TRIAL
Authors: BRODOWICZ T KOTZ R WILTSCHKE C ZIELINSKI CC RITSCHL P
Citation: T. Brodowicz et al., ISOLATED LIMB PERFUSION WITH HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA INCOMBINATION WITH INTERFERON-GAMMA AND MELPHALAN FOR NONRESECTABLE EXTREMITY SOFT-TISSUE SARCOMAS - A MULTICENTER TRIAL, Journal of clinical oncology, 15(5), 1997, pp. 2174-2174
PLASMA-EXCHANGE FOR TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENTS
Authors: KNOBL P RINTELEN C KORNEK G WILTSCHKE C KALHS P SCHWARZINGER I GLOBITS S STAUDINGER T LACZIKA K KYRLE P FRASS M
Citation: P. Knobl et al., PLASMA-EXCHANGE FOR TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENTS, Intensive care medicine, 23(1), 1997, pp. 44-50
THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IN CRITICALLY ILL PATIENTS
Authors: KNOBL P RINTELEN C KORNEK G WILTSCHKE C KYRLE P FRASS M
Citation: P. Knobl et al., THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IN CRITICALLY ILL PATIENTS, Thrombosis and haemostasis, 1997, pp. 1317-1317
BIOLOGICAL CONSEQUENCES OF MODULATION OF DEFECTIVE EXPRESSION OF ICAM-1 BY TUMOR-NECROSIS-FACTOR ON BREAST-CANCER CELLS IN-VITRO
Authors: ZIELINSKI CC BUDINSKY AC BRODOWICZ T CZERWENKA K KRAINER M WILTSCHKE C
Citation: Cc. Zielinski et al., BIOLOGICAL CONSEQUENCES OF MODULATION OF DEFECTIVE EXPRESSION OF ICAM-1 BY TUMOR-NECROSIS-FACTOR ON BREAST-CANCER CELLS IN-VITRO, Experimental hematology, 25(8), 1997, pp. 106-106
TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/
Authors: KRAINER M BRODOWICZ T ZEILLINGER R WILTSCHKE C SCHOLTEN C SEIFERT M KUBISTA E ZIELINSKI CC
Citation: M. Krainer et al., TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/, Oncology, 54(6), 1997, pp. 475-481
SOLUBLE HER-2 NEU NEUTRALIZES BIOLOGIC EFFECTS OF ANTI-HER-2/NEU ANTIBODY ON BREAST-CANCER CELLS IN-VITRO/
Authors: BRODOWICZ T WILTSCHKE C BUDINSKY AC KRAINER M STEGER GG ZIELINSKI CC
Citation: T. Brodowicz et al., SOLUBLE HER-2 NEU NEUTRALIZES BIOLOGIC EFFECTS OF ANTI-HER-2/NEU ANTIBODY ON BREAST-CANCER CELLS IN-VITRO/, International journal of cancer, 73(6), 1997, pp. 875-879
DECREASED EXPRESSION OF ICAM-1 AND ITS INDUCTION BY TUMOR-NECROSIS-FACTOR ON BREAST-CANCER CELLS IN-VITRO
Authors: BUDINSKY AC BRODOWICZ T WILTSCHKE C CZERWENKA K MICHL I KRAINER M ZIELINSKI CC
Citation: Ac. Budinsky et al., DECREASED EXPRESSION OF ICAM-1 AND ITS INDUCTION BY TUMOR-NECROSIS-FACTOR ON BREAST-CANCER CELLS IN-VITRO, International journal of cancer, 71(6), 1997, pp. 1086-1090
TC-99M-TETROFOSMIN SOFT-TISSUE SCANNING AND METASTATIC DISEASE
Authors: BERGHAMMER P WILTSCHKE C SINZINGER H ZIELINSKI CC
Citation: P. Berghammer et al., TC-99M-TETROFOSMIN SOFT-TISSUE SCANNING AND METASTATIC DISEASE, Lancet, 348(9035), 1996, pp. 1169-1170
A HYPERACTIVE ESTROGEN-RECEPTOR VARIANT IN HYPERPLASTIC BREAST-LESIONS
Authors: FUQUA SAW WILTSCHKE C LEMIEUX P WOLF DM
Citation: Saw. Fuqua et al., A HYPERACTIVE ESTROGEN-RECEPTOR VARIANT IN HYPERPLASTIC BREAST-LESIONS, Laboratory investigation, 74(1), 1996, pp. 79-79
A ROLE FOR ESTROGEN-RECEPTOR VARIANTS IN ENDOCRINE RESISTANCE
Authors: FUQUA SAW WILTSCHKE C CASTLES C WOLF D ALLRED DC
Citation: Saw. Fuqua et al., A ROLE FOR ESTROGEN-RECEPTOR VARIANTS IN ENDOCRINE RESISTANCE, Endocrine-related cancer, 2(1), 1995, pp. 19-25
IN-VIVO ADMINISTRATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR INCREASES NEUTROPHIL OXIDATIVE BURST ACTIVITY
Authors: WILTSCHKE C KRAINER M NANUT M WAGNER A LINKESCH W ZIELINSKI CC
Citation: C. Wiltschke et al., IN-VIVO ADMINISTRATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR INCREASES NEUTROPHIL OXIDATIVE BURST ACTIVITY, Journal of interferon & cytokine research, 15(3), 1995, pp. 249-253
CLINICAL RELEVANCE OF ESTROGEN-RECEPTOR VARIANTS IN BREAST-CANCER (VOL 6, PG 77, 1995)
Authors: WILTSCHKE C FUQUA SAW
Citation: C. Wiltschke et Saw. Fuqua, CLINICAL RELEVANCE OF ESTROGEN-RECEPTOR VARIANTS IN BREAST-CANCER (VOL 6, PG 77, 1995), Trends in endocrinology and metabolism, 6(5), 1995, pp. 159-159
CLINICAL RELEVANCE OF ESTROGEN-RECEPTOR VARIANTS IN BREAST-CANCER
Authors: WILTSCHKE C FUQUA SAW
Citation: C. Wiltschke et Saw. Fuqua, CLINICAL RELEVANCE OF ESTROGEN-RECEPTOR VARIANTS IN BREAST-CANCER, Trends in endocrinology and metabolism, 6(3), 1995, pp. 77-82
TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/
Authors: BRODOWICZ T KRAINER M ZEILLINGER R BUDINSKY AC WILTSCHKE C ZIELINSKI CC
Citation: T. Brodowicz et al., TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/, European journal of cancer, 31A, 1995, pp. 657-657
Risultati: 1-25 | 26-33